Abstract:Regulatory T (Treg) cells, an immunosuppressive subset of CD4+ T cells characterized by the expression of the master transcription factor forkhead box protein P3 (FOXP3), are a component of the immune system with essential roles in maintaining self-tolerance. In addition, Treg cells can suppress anticancer immunity, thereby hindering protective immunosurveillance of neoplasia and hampering effective antitumour immune responses in tumour-bearing hosts, thus promoting tumour development and progression. Identification of the factors that are specifically expressed in Treg cells and/or that influence Treg cell homeostasis and function is important to understanding cancer pathogenesis and to identifying therapeutic targets. Immune-checkpoint inhibitors (ICIs) have provided a paradigm shift in the treatment of cancer. Most immune-checkpoint molecules are expressed in Treg cells, but the effects of ICIs on Treg cells, and thus the contributions of these cells to treatment responses, remain unclear. Notably, evidence indicates that ICIs targeting programmed cell death 1 (PD-1) might enhance the immunosuppressive function of Treg cells, whereas cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors might deplete these cells. Thus, although manipulation of Treg cells is a promising anticancer therapeutic strategy, approaches to controlling these cells require further research. Herein, we discuss novel insights into the roles of Treg cells in cancer, which can hopefully be used to develop Treg cell-targeted therapies and facilitate immune precision medicine.

The functional regulation of Treg and its role in anti-tumor immunotherapy

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy

Regulatory T cells in immune checkpoint blockade antitumor therapy

The progression of regulatory T cells and tumor immunity

Molecular Mechanisms Underlying the Regulation and Functional Plasticity of FOXP3 + Regulatory T Cells

Different Subpopulations of Regulatory T Cells in Human Autoimmune Disease, Transplantation, and Tumor Immunity

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

Histone Acetyltransferase Mediated Regulation of FOXP3 Acetylation and Treg Function.

Regulatory T cells in tumor immunity

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy

Advance in the Study of CD4~+CD25~+FOXP3~+ Regulatory T Cell in Tumor Immune Evasion

The regulation of immune tolerance by FOXP3

Progress on Regulatory T Cells and Tumor

Regulatory T cells in cancer immunosuppression — implications for anticancer therapy

Immunotherapy of Cancer by Targeting Regulatory T cells

Regulatory T cell: a protection for tumour cells.

Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations